D3A ICD-10-CM Code: Benign neuroendocrine tumors
A clear reference for the official code description, hierarchy, and related coding information from the April 2026 U.S. release.
Code definition
Official description
D3ABenign neuroendocrine tumors
ICD-10-CM diagnosis code · United States clinical modification
Classification
Where D3A sits
- 1
Chapter 2
Neoplasms (C00-D49)
- 2
Section
Benign neuroendocrine tumors (D3A)
- 3
Category D3A
Benign neuroendocrine tumors
- 4
Code D3A
Benign neuroendocrine tumors
More specific choices
Codes under D3A
D3A is a non-billable category. Choose the child code that best matches the documented diagnosis.
Documentation details
Notes for this code
Inclusion terms
No inclusion terms are listed for D3A.
Code first
No “code first” instruction is listed for D3A.
Use additional code
No “use additional code” instruction is listed for D3A.
Excludes1
Conditions that should not be reported together with this code.
No Excludes1 note is listed for D3A.
Excludes2
Conditions not included here that may be reported separately when present.
- benign pancreatic islet cell tumors (D13.7)
Transparency
Source and release
This reference is generated from Vero’s ICD-10-CM description, hierarchy, and code-note dataset. The visible content and structured data share that source.
Review the CDC/NCHS ICD-10-CM sourceCode-specific guidance
Frequently asked questions
What does ICD-10-CM code D3A mean?
D3A is the April 2026 U.S. ICD-10-CM code for “Benign neuroendocrine tumors.”
Is D3A a billable or specific ICD-10-CM code?
No. D3A has more specific child codes in the April 2026 reference data. Select the code that matches the documentation and confirm the active code set and payer requirements.
Where is D3A located in ICD-10-CM?
D3A is listed in Chapter 2, Neoplasms (C00-D49), within Benign neuroendocrine tumors (D3A) (D3A–D3A), under category D3A, Benign neuroendocrine tumors.
What coding notes are listed for D3A?
No inclusion terms are listed for D3A in this reference record. No code-first instruction is listed. No Excludes1 note is listed. Excludes2 notes: benign pancreatic islet cell tumors (D13.7).
Ready to transform your clinical documentation?
Join Vero and see how effortless documentation can be.
No credit card required
Cancel anytime